Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Eger – page 15

247 clinical trials in Eger, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Eger at a glance
247
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

247 trials in Eger

Open in trial search

Colitis ulcerative

Not recruiting

Long-term safety study of filgotinib tablets in adults with ulcerative colitis who completed previous filgotinib treatment

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Study on the Effectiveness of OPT-302 and Ranibizumab for Patients with Wet Age-related Macular Degeneration

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:OPT-302
  • Sponsor:Opthea Limited

Breast cancer

Not recruiting

Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Astrazeneca AB

Hypertriglyceridaemia

Not recruiting

Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Study of Efgartigimod for Adults with Thyroid Eye Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Major depression

Not recruiting

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aticaprant
  • Sponsor:Janssen - Cilag International

Cardiac failure acute

Not recruiting

Study of dapagliflozin effects in patients hospitalized with acute heart failure

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin Propanediol Monohydrate
  • Sponsor:The Brigham And Women’s Hospital Inc.

Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Astrazeneca AB

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Domvanalimab
  • Sponsor:Astrazeneca AB

Crohn's disease

Not recruiting

Study on the Effects of Ozanimod for Children with Moderate to Severe Crohn's Disease Not Responding to Usual Treatments

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ozanimod
  • Sponsor:Celgene International II S.a.r.l.

Study on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Doxycycline Hyclate
  • Sponsor:Polypid Ltd.

Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Eger

What the registry says about research in the country

01 Oncology Research

Advanced clinical trials focusing on bladder cancer treatments and innovative therapies for metastatic breast cancer. Studies evaluate new combination treatments and their effectiveness in improving patient outcomes.

  • Bladder Cancer Immunotherapy
  • Metastatic Breast Cancer Treatment
  • Colorectal Cancer Therapies

Multiple trials investigating targeted treatments for various stages of cancer, including new approaches for KRAS/NRAS mutations.

02 Hematological Disorders

Comprehensive research into blood-related conditions, including B-cell malignancies and various forms of leukemia. Studies focus on novel therapeutic approaches and combination treatments.

  • Chronic Lymphocytic Leukemia
  • Diffuse Large B-cell Lymphoma
  • Myelodysplastic Syndrome

Innovative treatments being evaluated for both newly diagnosed and relapsed/refractory conditions.

03 Chronic Conditions

Studies addressing various chronic conditions, including osteoarthritis and autoimmune disorders. Research focuses on pain management and improving patient mobility.

  • Knee Osteoarthritis Treatment
  • Rheumatoid Arthritis Management
  • Sjögren's Syndrome Therapy

Evaluating both conventional and innovative treatment approaches for chronic inflammatory conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.